Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Novartis
Colorcon
Queensland Health
Dow
Harvard Business School
Accenture
Daiichi Sankyo
Teva
Medtronic

Generated: December 11, 2017

DrugPatentWatch Database Preview

Sun Pharm Inds Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS LTD, and when can generic versions of SUN PHARM INDS LTD drugs launch?

SUN PHARM INDS LTD has one hundred and sixteen approved drugs.

There are eight US patents protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.

There are thirty-one patent family members on SUN PHARM INDS LTD drugs in nineteen countries and one hundred and thirty-two supplementary protection certificates in thirteen countries.

Summary for Sun Pharm Inds Ltd

International Patents:31
US Patents:8
Tradenames:89
Ingredients:86
NDAs:116
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds LtdLISINOPRIL AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; lisinoprilTABLET;ORAL076007-003Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdQUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; quinapril hydrochlorideTABLET;ORAL078211-003Mar 4, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdXIMINOminocycline hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL201922-003Jul 11, 2012RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdMINOCYCLINE HYDROCHLORIDEminocycline hydrochlorideTABLET, EXTENDED RELEASE;ORAL091118-006Sep 25, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdCARVEDILOLcarvedilolTABLET;ORAL076989-004Sep 5, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdHYDROCODONE BITARTRATE AND ACETAMINOPHENacetaminophen; hydrocodone bitartrateTABLET;ORAL040826-001Aug 16, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdACYCLOVIRacyclovirTABLET;ORAL074980-001Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdCARVEDILOLcarvedilolTABLET;ORAL076989-001Sep 5, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL201633-001Aug 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdOXYMORPHONE HYDROCHLORIDEoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL203506-006Apr 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Sun Pharm Inds Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds LtdULTRAVATEhalobetasol propionateCREAM;TOPICAL019967-001Dec 27, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Sun Pharm Inds Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,559,187 Liquid formulation of metformin► Subscribe
9,192,615Method for the treatment of acne and certain dosage forms thereof► Subscribe
8,722,650Extended-release minocycline dosage forms► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Sun Pharm Inds Ltd Drugs

Country Document Number Estimated Expiration
South Africa200300990► Subscribe
Japan2013213047► Subscribe
World Intellectual Property Organization (WIPO)0211716► Subscribe
European Patent Office1898925► Subscribe
Australia7659801► Subscribe
Israel188331► Subscribe
Iceland6709► Subscribe
China101208097► Subscribe
Japan5744976► Subscribe
Japan2008543936► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00445Netherlands► SubscribePRODUCT NAME: VALSARTAN, AMLODIPINE EN HYDROCHLOORTHIAZIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/09/569/001-060 20091016
C/GB98/047United Kingdom► SubscribePRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825
0677Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN DAPAGLIFLOZINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN METFORMINE OF EEN FARMACEITISCH AANVAARDBAAR ZOUT DAARVAN, ZOALS BESCHERMD DOOR HET BASISOCTROOI EP 1506211B1; REGISTRATION NO/DATE: EU/1/13/900 20140121
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
2011005,C0984957Lithuania► SubscribePRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
1730131/02Switzerland► SubscribePRODUCT NAME: EMPAGLIFLOZIN UND METFORMINHYDROCHLORID; REGISTRATION NO/DATE: SWISSMEDIC 65570 12.11.2015
00357Netherlands► SubscribePRODUCT NAME: SITAGLIPTINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZOUT, IN HET BIJZONDER HET MONOFOSFAAT, EN METFORMINE DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716
C/GB11/015United Kingdom► SubscribePRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
1506211/02Switzerland► SubscribePRODUCT NAME: DAPAGLIFLOZIN + METFORMIN; REGISTRATION NO/DATE: SWISSMEDIC 65377 16.07.2015
C/GB98/041United Kingdom► SubscribePRODUCT NAME: RIVASTIGMINE, AS FREE BASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: CH 5427501 19970731; CH 5427502 19970731; CH 5427503 19970731; CH 5427504 19970731; CH 5427505 19970731; CH 5427506 19970731; UK EU/1/98/066/001 19980512; UK EU/1/98/066/002 19980512; UK EU/1/98/066/003 19980512; UK EU/1/98/066/004 19980512; UK EU/1/98/066/005 19980512; UK EU/1/98/066/006 19980512; UK EU/1/98/092/023 19980512; UK EU/1/98/092/024 19980512; UK EU/1/98/092/025 19980512; UK EU/1/98/092/026 19980512; UK EU/1/98/066/025 19980512; UK EU/1/98/066/026 19980512; UK EU/1/98/092/019 19980512; UK EU/1/98/092/020 19980512; UK EU/1/98/092/021 19980512; UK EU/1/98/092/022 19980512; UK EU/1/98/0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
McKesson
Julphar
Federal Trade Commission
Harvard Business School
Moodys
Chubb
US Army
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot